Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this patient population DATROWAY also demonstrated a highly statistically significant and clinically meaningful improvement in the dual primary endpoint of progression-free survival Plans for global regulatory submissions are underway TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Positive topline … [Read more…]

Kronos, once valued at $3.5B, Had Two Phase 2 Stage Assets CAMBRIDGE, England–(BUSINESS WIRE)–Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos’s clinical assets, istisociclib, a CDK9 inhibitor, and entospletinib and lanraplenib, SYK inhibitors. Kronos’ valuation peaked at $3.5 billion after its IPO; however, it failed to progress its assets past … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it has completed the Initial Closing of the Non-brokered Private Placement to accredited investors announced in its Press Release dated July 25, 2025. The Initial Closing comprised the issuance of 7,033,000 Units (as described below) and raised cash proceeds … [Read more…]

Anniversary celebration Kicks off at AHF’s original AIDS thrift store location Saturday, October 4th Celebration: 10:00 a.m. – 2:00 p.m. Atwater Village LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) will mark the 35th anniversary of its award-winning Out of the Closet (OTC) thrift store chain with a celebration and anniversary sale on Saturday, October 4th at … [Read more…]

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia’s biotechnology ecosystem. The relocation of BUILT’s headquarters to CvilleBioHub’s state-of-the-art facilities at North Fork Research Park positions the company to rapidly scale production in a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Lymphoma Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030” report has been added to ResearchAndMarkets.com’s offering. This report gives comprehensive overview of the current scenario of antibody drug conjugates in lymphoma therapy. It identifies the recent clinical trials, technology advancements, and market players influencing the market. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biologics Contract Research Organization Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biologic, Scale of Operation, Therapeutic Area, and Geography” report has been added to ResearchAndMarkets.com’s offering. The global biologics contract research organization market, valued at USD 21.5 billion in 2025, is anticipated to grow at a lucrative CAGR … [Read more…]

LUXEMBOURG–(BUSINESS WIRE)–Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY … [Read more…]

– Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte study – – First and only combination therapy for the first-line maintenance treatment of ES-SCLC, which is critical to help address the high rate of relapse in ES-SCLC – – Regimen recommended … [Read more…]

Study and red-teaming exercise led by Microsoft brought together consortium of scientific and industry experts Twist remains at the forefront of biosecurity innovation, demonstrating leadership in both policy engagement and technical solutions SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced the publication in Science of … [Read more…]